Abiopharma

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

Clearmind Medicine Successfully Regains Compliance with Nasdaqs Minimum Stockholders Equity Requirement

ImmunityBio Receives Conditional Marketing Authorization Recommendation from the European Medicines Agency for ANKTIVA® with BCG for Non-Muscle Invasive Bladder Cancer Carcinoma in Situ—A First in Europe

West to Participate in Upcoming Investor Conference

Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

Latest About iPod Nano 7th Generation

Shark FlexStyle vs Dyson Airwrap